ArticleFrontiers in oncology2022

A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune Cells.

Youg R Thaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.